Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.

Autor: Ronner L; Icahn School of Medicine at Mount Sinai, New York, NY., Podoltsev N; Hematology Section, Department of Medicine, Yale School of Medicine, New Haven, CT., Gotlib J; Stanford Cancer Institute, Stanford, CA., Heaney ML; Columbia University Medical Center, New York, NY., Kuykendall AT; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., O'Connell C; Keck School of Medicine, University of Southern California, Los Angeles, CA., Shammo J; Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL., Fleischman AG; Division of Hematology and Oncology, Chao Family Comprehensive Cancer Center, UCI Health, Irvine, CA., Scherber RM; Division of Hematology and Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX., Mesa R; Division of Hematology and Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX., Yacoub A; University of Kansas Cancer Center, Westwood, KS., Perkins C; Stanford Cancer Institute, Stanford, CA., Meckstroth S; Yale School of Public Health, New Haven, CT., Behlman L; Hematology Section, Department of Medicine, Yale School of Medicine, New Haven, CT., Chiaramonte M; Columbia University Medical Center, New York, NY., Salehi M; Keck School of Medicine, University of Southern California, Los Angeles, CA., Ziadkhanpour K; Icahn School of Medicine at Mount Sinai, New York, NY., Nguyen H; Division of Hematology and Oncology, Chao Family Comprehensive Cancer Center, UCI Health, Irvine, CA., Siwoski O; University of Kansas Cancer Center, Westwood, KS., Hung AK; Division of Hematology and Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX., Janania Martinez M; Division of Hematology and Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX., Nguyen J; Division of Hematology and Oncology, Chao Family Comprehensive Cancer Center, UCI Health, Irvine, CA., Patel S; Keck School of Medicine, University of Southern California, Los Angeles, CA., Kollipara R; Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL., Dave A; Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL., Randall M; Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL., Grant M; Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL., Harrison M; Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL., Fernandez Soto P; Division of Hematology and Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL., Tremblay D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; and., Hoffman R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; and., Moshier E; Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; and.

Publikováno v: Blood [Blood] 2020 May 07; Vol. 135 (19), pp. 1696-1703.